INT-767
≥98%
- Product Code: 101007
CAS:
1000403-03-1
| Molecular Weight: | 494.66 g./mol | Molecular Formula: | C₂₅H₄₃NaO₆S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
INT-767 is primarily investigated for its therapeutic potential in metabolic and liver-related disorders. It acts as a dual agonist for farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5), making it effective in regulating bile acid homeostasis, glucose metabolism, and inflammation. In preclinical studies, it has shown promise in treating non-alcoholic steatohepatitis (NASH) by reducing liver inflammation, fibrosis, and lipid accumulation. Additionally, it has been explored for its role in improving insulin sensitivity and managing type 2 diabetes. Its anti-inflammatory properties also make it a candidate for addressing inflammatory bowel disease (IBD) and other immune-related conditions. Research continues to evaluate its efficacy and safety in clinical applications.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | ฿35,910.00 |
+
-
|
| 0.005 | 10-20 days | ฿76,950.00 |
+
-
|
INT-767
INT-767 is primarily investigated for its therapeutic potential in metabolic and liver-related disorders. It acts as a dual agonist for farnesoid X receptor (FXR) and Takeda G protein-coupled receptor 5 (TGR5), making it effective in regulating bile acid homeostasis, glucose metabolism, and inflammation. In preclinical studies, it has shown promise in treating non-alcoholic steatohepatitis (NASH) by reducing liver inflammation, fibrosis, and lipid accumulation. Additionally, it has been explored for its role in improving insulin sensitivity and managing type 2 diabetes. Its anti-inflammatory properties also make it a candidate for addressing inflammatory bowel disease (IBD) and other immune-related conditions. Research continues to evaluate its efficacy and safety in clinical applications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :